Becton Dickinson Poked By Syringe Antitrust Suit

Law360, New York (June 9, 2006, 12:00 AM EDT) -- Medical technology company UltiMed Inc. has filed an antitrust lawsuit against its embattled rival, Becton Dickinson & Co., accusing the much larger company of barring competition in the market for home-use insulin syringes.

The complaint targets exclusionary contracts allegedly used by Becton Dickinson to prevent pharmacies from offering insurance discounts to consumers of non-Becton Dickinson syringes—typically used by diabetics.

Filed in the U.S. District Court for the District of Minnesota, the lawsuit is similar to several antitrust complaints filed against Becton Dickinson in 2005, as well...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.